Sign in with Google
|
USD 89.76
Price
1.13
(1.27%)
Day Change
|
|
|---|
GILD, the overall quality is good (Quality = 77) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Good
- Reason
-
P/E ratio is relatively high
ROE is relatively low.
ROE is decreasing significantly
Net profit margin is relatively low.
In details, quality factors are not quite good , financial health is not quite good , and ability to make profit is good , ...
| Quality Factors |
|
51% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| Social Score | 2 |
| Magic Formula Rank by ROA |
1884
|
| Magic Formula Rank by ROE |
1884
|
| Magic Formula Rank by ROIC |
2060
|
| Price | 89.76 |
| PBV / Sector |
5.98 / 11.55
|
| Earning Per Share | 0.09 |
| PE / Sector |
975.00 / 30.94
|
| PEG or PE/Growth / Sector |
0.52 / 1.34
GOOD
|
| Average 1M Daily Value |
665.78 M
|
| Average 1W Daily Value |
652.33 M
|
| Timing Factors |
|
42% |
| Financial Health |
|
52% |
| Ability to Make Profit |
|
70% |
| Return to Investors |
|
33% |
| Registration Details |
| Analyze Date | 2024-11-21 20:05:05 |
| Symbol | GILD |
| Name | GILEAD SCIENCES INC |
| Sector | Healthcare >> Drug Manufacturers - General |
| Market | NASDAQ |
| Listed Shares | 1,246.27 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 109,360.19 / 215,531.71 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
AZN 
MRK 
NVS 
